Presentation EuroPCR 2013 Clinical evidence in catheter-based renal sympathetic denervation - building the data Presenter: 161082|Joachim Schofer May 31, 2013 REGISTER for free or LOG IN to view this content Renovascular Presentation EuroPCR 2013 Up Next Presentation EuroPCR 2013 Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent Presenter: 203171|Ian Meredith May 31, 2013 More slides + Presentation EuroPCR 2013 One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study Presenter: 13956|Raul Moreno May 31, 2013 Presentation What is the Best Initial Management Strategy for Stable Ischemic Heart Disease? Presenter: 218868|Judith Hochman May 31, 2013 We Recommend
Presentation EuroPCR 2013 Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent Presenter: 203171|Ian Meredith May 31, 2013
Presentation EuroPCR 2013 One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study Presenter: 13956|Raul Moreno May 31, 2013
Presentation What is the Best Initial Management Strategy for Stable Ischemic Heart Disease? Presenter: 218868|Judith Hochman May 31, 2013